-
Taxonomy & unit
-
ratio: %
-
Description
-
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
-
Summary
-
Vistagen Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2012 to 2023.
- Vistagen Therapeutics, Inc. Return On Equity for the quarter ending December 31, 2024 was -48.1 %, a 33.3% increase year-over-year.
- Vistagen Therapeutics, Inc. annual Return On Equity for 2023 was -108 %, a 42.1% decline from 2022.
- Vistagen Therapeutics, Inc. annual Return On Equity for 2022 was -76.2 %, a 26.4% increase from 2021.
- Vistagen Therapeutics, Inc. annual Return On Equity for 2021 was -104 %, a 120% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)